Globalisation

News in brief

Brazil wants to buy Pharma tech from the Ukraine

20-Nov-2012 - Brazil wants to buy pharmaceutical manufacturing technology from the Ukraine as part of a $4.5bn investment plan.

News from CPhI

India will back pharma SMEs in $500m finance scheme

20-Nov-2012 - The Indian Government plans to offer financial assistance to small and medium pharma enterprises (SMEs) in a bid to drive the industry.

Indian regulations will hike costs but market will remain competitive, Government tells IPT

15-Nov-2012 - Domestic regulatory efforts to improve ingredient quality will increase costs but Indian industry will remain competitive, according to the Secretary of Commerce.

EXCLUSIVE - update

Source bovine materials from BSE-free Australia or NZ: CEO's plea to regulators

14-Nov-2012 - Regulators should force pharmaceutical firms to source from BSE-safe countries according to Rocky Mountain Biologicals' CEO.

Evonik hikes amino acid prices in face of rising maize and sugar costs

24-Oct-2012 - Evonik has raised the price of its pharmaceutical amino acids as a result of rising maize and sugar costs.

Indian pharma regulations should not change to suit others, says the Government

15-Oct-2012 - Indian regulations should not change to suit Western GMP standards, according to the country’s Deputy Drug Controller.

Mutual recognition agreements will solve global GMP woes, says EFCG

10-Oct-2012 - Mutual recognition agreements between Western regulators would help ensure a safe API supply chain, according to the EFCG.

CPhI Worldwide 2012: Networking, up-coming countries and bioavailability

08-Oct-2012 - in-Pharmatechnologist.com is going to Madrid, Spain to meet API and excipient makers, Biopharma firms, processing tech developers and contract services organisation gathered for one of the drug industry's biggest trade shows....

Symbiosis opens new injectables plant for APIs and biologics

08-Oct-2012 - Symbiosis has opened a new sterile manufacturing facility in Scotland for production of both pharma and biopharma products.

EXCLUSIVE

EMA biosimilar guidance welcomed but has further to go, say EGA, Aptuit and Charles River

04-Oct-2012 - Latest EMA biosimilar guidance on reference products is a “major breakthrough” but there is still work to do, say industry experts.

EMA will accept reference meds made outside Europe under biosimilars guidelines

03-Oct-2012 - The EMA plans to accept reference medicines sourced from outside the European Economic Area (EEA) under its updates biosimilar guidance.

Alchem ups sennoside production in face of pharma demand

25-Sep-2012 - Alchem International has expanded its sennosides production facility in India in a bid to meet pharma demand.

Health Canada rubbishes Cassels comments through IPT

17-Sep-2012 - Health Canada has hit back at claims it is “secretive” about its overseas supply chain because it is unsafe.

Continued biopharma growth for Pall

13-Sep-2012 - Pall Corporation has once again hailed its biopharma consumables business a key factor in its sales growth.

Takeda plans to dominate thriving Russian pharma market, starting with a new plant

11-Sep-2012 - Takeda has opened a new $96m (€75m) pharma facility in Russia as part of its bid to “outgrow” the already thriving local market.

EXCLUSIVE (updated)

Could the new WHO initiative put too much strain on ARV production in SA? UCLA and Aspen speak

05-Sep-2012 - Researchers from UCLA say the WHO’s latest proposal to “test and treat” the entire population of South Africa for HIV every year is unrealistic.

Hospira buys Indian API plant to boost antibiotics biz

30-Aug-2012 - Hospira has bought Orchid Chemicals and Pharmaceutical’s active pharmaceutical ingredient (API) facility in Aurangabad, India, to support its expanding antibiotic business.

New sustained release hydrogel could mean twice-yearly injections for diabetes sufferers

16-Aug-2012 - A new hydrogel which can provide a sustained drug release of up to six months could cut diabetes dosage down from 365 injection per year to just two, according to researchers.

Theorem and Gallus team up to help drugsmakers in emerging markets go State side

16-Aug-2012 - Theorem and Gallus say their new biologics manufacturing partnership is aimed at giving a “leg up” to drugsmakers in emerging markets looking to market products in the US.

US Government must 'get a handle' on biosecurity, say experts

14-Aug-2012 - US biosecurity experts are calling on industry and the Government to “get a handle” on the supply chain for drugs used in times of pandemic or bio attack.

Aurobindo sets eyes on API CRAMS biz

08-Aug-2012 - Aurobindo has announced long term plans to steer away from its generics making business in a bid to focus on long term API manufacturing partnerships.

Religion plays big part in pharma gelatine shortage for India: Beroe

17-Jul-2012 - Religion is playing a big part in increasing gelatine woes for Indian drugsmakers, according to Beroe.

Expert backs global risk-benefit framework at BIO2012

20-Jun-2012 - A risk-benefit assessment framework for new drugs is a must for Pharmas, a leading industry expert told attendees at BIO 2012 in Boston.

Indian SMEs need Gov support to comply with GMPs; report

14-Jun-2012 - The Indian Government must better support modernisation efforts at small businesses to boost GMP compliance, a report found.

FDA warns 8 manufacturers for failing to register plants

07-Jun-2012 - The US FDA has sent warning letters to eight biopharma companies for failing to register production facilities.